25 related articles for article (PubMed ID: 8425770)
1. Ricin A-chain conjugated with monoclonal anti-L1210 antibody. In vitro and in vivo antitumor activity.
Kishida K; Masuho Y; Saito M; Hara T; Fuji H
Cancer Immunol Immunother; 1983; 16(2):93-7. PubMed ID: 6559105
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of Actinobacillus suis cells in combination with 5-fluorouracil on mice bearing murine L1210 leukemia cells.
Watanabe T; Itoh S
Cancer Immunol Immunother; 1997 Jun; 44(4):216-20. PubMed ID: 9222280
[TBL] [Abstract][Full Text] [Related]
3. Acquisition of multidrug resistance by L1210 leukemia cells decreases their tumorigenicity and enhances their susceptibility to the host immune response.
Martín-Orozco E; Ferragut JA; Garcia-Peñarrubia P; Ferrer-Montiel A
Cancer Immunol Immunother; 2005 Apr; 54(4):328-36. PubMed ID: 15692844
[TBL] [Abstract][Full Text] [Related]
4. Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.
Marchini S; Cirò M; Gallinari F; Geroni C; Cozzi P; D'Incalci M; Broggini M
Br J Cancer; 1999 Jun; 80(7):991-7. PubMed ID: 10362106
[TBL] [Abstract][Full Text] [Related]
5. Tallimustine in advanced previously untreated colorectal cancer, a phase II study.
Punt CJ; Humblet Y; Roca E; Dirix LY; Wainstein R; Polli A; Corradino I
Br J Cancer; 1996 Mar; 73(6):803-4. PubMed ID: 8611384
[TBL] [Abstract][Full Text] [Related]
6. Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine).
Ciomei M; Pastori W; Capolongo L; Geroni C; Melegaro G; Pennella G; Grandi M
Br J Cancer; 1995 Dec; 72(6):1504-8. PubMed ID: 8519667
[TBL] [Abstract][Full Text] [Related]
7. Patterns of resistance and therapeutic synergism among alkylating agents.
Schabel FM; Trader MW; Laster WR; Wheeler GP; Witt MH
Antibiot Chemother (1971); 1978; 23():200-15. PubMed ID: 348078
[TBL] [Abstract][Full Text] [Related]
8. Development of drug derivatives without cross-resistance to parent compounds.
Scheulen ME
Cancer Treat Rev; 1990 Dec; 17 Suppl A():67-79. PubMed ID: 1965493
[No Abstract] [Full Text] [Related]
9. Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies.
Geroni C; Pesenti E; Tagliabue G; Ballinari D; Mongelli N; Broggini M; Erba E; D'Incalci M; Spreafico F; Grandi M
Int J Cancer; 1993 Jan; 53(2):308-14. PubMed ID: 8425770
[TBL] [Abstract][Full Text] [Related]
10. Intracellular glutathione heterogeneity in L1210 murine leukemia sublines made resistant to DNA-interacting anti-neoplastic agents.
Tagliabue G; Pifferi A; Balconi G; Mascellani E; Geroni C; D'Incalci M; Ubezio P
Int J Cancer; 1993 May; 54(3):435-42. PubMed ID: 8509218
[TBL] [Abstract][Full Text] [Related]
11. Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.
Pezzoni G; Grandi M; Biasoli G; Capolongo L; Ballinari D; Giuliani FC; Barbieri B; Pastori A; Pesenti E; Mongelli N
Br J Cancer; 1991 Dec; 64(6):1047-50. PubMed ID: 1764367
[TBL] [Abstract][Full Text] [Related]
12. Selective DNA interaction of the novel distamycin derivative FCE 24517.
Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).
Capolongo L; Melegaro G; Broggini M; Mongelli N; Grandi M
Br J Cancer; 1993 Nov; 68(5):916-9. PubMed ID: 8105866
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic and antitumor activity of MEN 10710, a novel alkylating derivative of distamycin.
Bigioni M; Salvatore C; Palma C; Manzini S; Animati F; Lombardi P; Pratesi G; Supino R; Zunino F
Anticancer Drugs; 1997 Oct; 8(9):845-52. PubMed ID: 9402311
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
